BioScrip to take Q4 charges
-
- February
- 2
BioScrip Inc., a pharmacy benefits manager in Elmsford, said it will take an after-tax, non-cash charge of $80 million against its fourth-quarter earnings for the impairment of goodwill and the write off of assets to comply with an accounting rule.
The company said the action is the result of poor market conditions that caused a decrease in the company’s stock price.
As a result, the company will report a net loss for the fourth quarter and for 2008.
Stanley G. Rosenbaum, the company’s chief financial officer, said: “Despite the current economic environment, we remain optimistic about the growtyh potential of our specialty pharmacy business.”
The company plans to announce its fourth-quarter earnings on March 3.
This entry was posted
on Monday, February 2nd, 2009 at 10:59 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Category: Corporate doings
Print
| 
Email
